37th International Symposium on ALS/MND

Amsterdam, the Netherlands

Wednesday 9 December – Friday 11 December 2026

  • Home
  • About
    • About the event
    • Past symposia
    • Future dates
    • Sign up for updates
  • Sponsor/Exhibitor
    • Sponsors and Exhibitors
    • Sponsor recognition programme
  • For Presenters
    • For Oral Presenters
    • For Poster Presenters
    • Research awards
    • Abstract Submission
  • Plenary speakers
  • First announcement
    • First announcement
  • Location
    • About Amsterdam
    • Venue
    • Accommodation
  • Register
  • Menu
Home » Latest News » Phase 3 clinical trial results – levosimendan

Phase 3 clinical trial results – levosimendan

Posted on by Symposium Admin
Posted in Latest News.

Post navigation

← Virtual Symposium: Through the eyes…
Health and social care retrospective:… →
logo
  • Contact
  • Sitemap
  • Cookies Policy
  • Privacy Policy
  • Terms and Conditions
  • Sign up for updates

Follow us

  • facebook
  • twitter
  • youtube
  • instagram
© 2026 MND Association: Registered in England at Francis Crick House, 6 Summerhouse Road, Moulton Park, Northampton, NN3 6BJ. Registered Charity no. 294354. VAT Registration no. 316 4340 28.
A SiteOrigin Theme